Acquire 20% New Business Leads - Your Profit Accelerator
01
identify new opportunities
TWO Oncology reports
360 Degree Insights on Drug Development
2485 Active Cancer Drug Developers.
4785 Active Molecules in Development.
1700+ Deals & Partnering Details.
Special coverage on CAR-T, Vaccines, ADCs, Monoclonal Antibodies, Oncolytic Viruses and Small molecule Kinase Inhibitors.
Emerging Technologies like Microbiome, CRISPER, Exosomes, RNAi etc., as Cancer treatment are covered.
Decode the ADC drug development landscape in seconds—powered by curated intelligence, supervised learning, and 15+ years of domain expertise.
Decode the ADC drug development landscape in seconds—powered by curated intelligence, supervised learning, and 15+ years of domain expertise.
Intelligence +
Strategic Marketing for Business Development Professionals
Perfect B2B Solution to Identify New Leads & Connect in Minutes.
-
UNIQUE SOLUTION - Combining CRM with Intelligence -
All at SINGLE PLATFORM. - Validated Active Key Accounts with social profiles and intelligence prefilled.
-
Can also be Integrated with INDUSTRY BEST CRM (HubSpot/Salesforce) in minutes.
Can be Used to update your existing CRM Data. - Currently Available for Oncology & Neurology Drug Developers.
- Post Purchase COMPLETE FREE SUPPORT for 3 months in providing updates on in Key Accounts Positions changes.